4 articles
Haleon boosted US sales by partnering with retailers like CVS to stock items addressing GLP-1 weight-loss drug side effects. The strategy yielded a 24% sales lift per store in Q1 amid rising demand fo
Haleon secured improved shelf placements at Walmart and Target via competitive terms, boosting its U.S. consumer health market share to 12% by August amidst cost-conscious consumer trends.
Haleon reported a first-half profit beat but saw shares slip due to weak European demand and falling respiratory sales. While operating profits exceeded expectations, analysts remain cautious about me
Unilever is exploring a bid for U.S. supplements maker Thorne, valued at up to $4 billion, to accelerate its pivot toward wellbeing brands. Thorne produces dietary supplements such as magnesium and om
ChemBrief